Clinical Trial Update: Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating artesunate in combination with standard of care for active lupus nephritis to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Artesunate (artesunate)
• Standard of Care

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lupus Nephritis | Phase 4 | Status: UNKNOWN